Improving How Drugs Go To Market
OUR MISSION
Speed & Accuracy
SignAIture enhances speed and accuracy in pharmaceutical quality control by leveraging AI-driven spectroscopy for real-time, non-destructive analysis. Traditional testing methods are often slow, requiring extensive sample preparation and lab processing, while SignAIture’s technology enables instant, full-depth scanning to detect moisture variations, composition inconsistencies, and contaminants with high precision.
By integrating advanced machine-learning algorithms, SignAIture improves detection accuracy over time, minimizing errors and optimizing decision-making. This ensures faster production cycles, reduced waste, and greater consistency in drug manufacturing. With its seamless, automated approach, SignAIture helps pharma producers meet growing industry demands while maintaining regulatory compliance, operational efficiency, and product safety.
WHO WE ARE
Meet the Founders
SignAIture was founded by Anas and Zifu, two industry veterans with deep expertise in AI, electromagnetics, and product innovation. Anas, a prolific inventor with 80+ patents, has led groundbreaking advancements in wireless and food technology and played a key role in self-driving tech at CAT. Zifu, with a PhD in Electrical Engineering, brings extensive experience in electromagnetic sensing, electric vehicle systems, and AI-driven product development. Together, they are revolutionizing pharmaceutical quality control with cutting-edge AI-driven spectroscopy to enhance speed, accuracy, and efficiency.
Anas Alfarra
CEO
- Self Driving Leadership @CAT
- 81 patents in Wireless & Autonomy tech
- Extensive startup experience
- Wharton Executive MBA
Zifu Wang, PhD
CTO
- eDrive Director @HITACHI
- PhD Electromagnetics (Post-doc @Umich)
- Startup Experience leading to IPO
- Wharton Executive MBA
PRESS
SigAIture under the hood
SignAIture was incubated through Wharton Venture Lab’s VIP-X program, a premier accelerator supporting high-potential startups. The company has also received the Wharton Innovation Fund and the Wharton Summer Award, recognizing its groundbreaking approach to AI-driven spectroscopy. With strong backing from Wharton’s entrepreneurial ecosystem, SignAIture is poised to revolutionize pharmaceutical quality control by delivering faster, more accurate, and non-destructive testing solutions.
